Influenza Diagnostics Market Trend, Segmentation And Industry Analysis Research Report 2017
The Global Influenza Diagnostics
Market is growing with the rapid pace; mainly due the burgeoning Healthcare
Sector. According to a recent study report published by the Market Research
Future, The global Influenza Diagnostics Market is booming and expected to gain
prominence over the forecast period.
Global Influenza
Diagnostics Market information, by type of flu (Type A flu, type B flu,
Type C flu), by Test type (Molecular Tests, Rapid Influenza Detection Tests
(RIDT), Direct Fluorescent Antibody (DFA) Tests, Nucleic Acid Sequence-based
Amplification (NASBA) Tests, Serological Assays, Simple Amplification-based
Assays (SAMBA), Loop-mediated Isothermal Amplification-based Assays (LAMP), and
Others), by End User ( Hospital and clinics, Research laboratories, Educational
institutions, and others) - Forecast to 2023
Global Influenza Diagnostics Market is growing
moderately. Influenza or flu is one of the common medical condition which occur
in seasonal epidemics and shows an acute illness with variable degrees of
systemic symptoms which ranges from mild fatigue to respiratory failure and
death. Influenza B is most common type of flu. Influenza infection can create
health complications which may be deadly, but early diagnosis of influenza can
reduces the chances of further complications. According the World Health
organization, there are almost 600 million cases of influenza worldwide. The increasing
demand for advanced diagnostic products and kits, increasing R&D funding
for new innovative products and increasing healthcare expenditure are major
driving factors for this market. The Global Influenza Diagnostics market is
expected to reach US$ 700.7 million by 2023 and is projected to grow at the
CAGR of ~5.8% during the forecast period from 2017-2023.
Segments:
Global Influenza Diagnostics Market has been
segmented on the basis of type of flu which comprise Type A flu (Seasonal flu,
Swine Flu, Bird Flu), type B flu, Type C flu. On the basis of type of test it
segmented into Molecular Tests, Rapid Influenza Detection Tests (RIDT), Direct
Fluorescent Antibody (DFA) Tests, Nucleic Acid Sequence-based Amplification
(NASBA) Tests, Serological Assays, Simple Amplification-based Assays (SAMBA),
Loop-mediated Isothermal Amplification-based Assays (LAMP), and Others. Serological
assays further sub segmented into Primary Serological tests (Enzyme linked
immunosorbent assay (ELISA), Immuno fluorescent antibody technique (IFAT),
Radio immuno assay (RIA), Secondary Serological tests (Agglutination tests,
Complement fixation tests (CFT), Precipitation tests, Serum neutralization
tests (SNT), Toxin-antitoxin test), and Tertiary serological tests.
Key Players for Global Influenza
Diagnostics Market:
Some of the key players in this market are: Alere
(US), BD (US), Becton, Dickinson and Company (U.S.), Cepheid (US), bioMérieux
SA (France), Hardy Diagnostics(us), LifeSign LLC.(US), Meridian Bioscience,
Inc.(US), Quidel Corporation (US), Roche Molecular Systems Inc.(Switzerland),
Sekisui Diagnostics (US)
Study objectives of Global
Influenza Diagnostics Market:
To provide detailed analysis of the
Global Influenza Diagnostics market structure with historical and forecasted
revenue for the next 6 years of the various segments and sub-segments of the
influenza diagnostics Market
To provide insights about the key
drivers, restraints, opportunities and challenges that affecting the growth of
the Influenza Diagnostics market
To provide analysis of the market
with respect to four main geographies and their countries- Americas, Europe,
Asia-Pacific, and Middle East & Africa.
To provide detail analysis of the market
that segmented on the basis of type of flue, test type, by end user, and its
sub-segments.
To provide detail analysis of global
Influenza Diagnostics market mainly based on Value chain analysis, Porter’s
five forces, Price analysis, and Supply Chain analysis etc.
To provide detail country level
analysis of the market with respect to the current market size and future
prospective
To track and analyze competitive
developments such as joint ventures, strategic alliances, mergers and
acquisitions, new product developments, and research and developments in the
Global Influenza Diagnostics Market
To provide overview of key players
and their strategic profiling in the market, comprehensively analyzing their
core competencies, and drawing a competitive landscape for the market
Regional Analysis of Global
Influenza Diagnostics Market:
Considering the global scenario of the market,
North America is believed to be the largest market for Global Influenza
Diagnostics due to advanced healthcare facilities and increasing presence of
major players in this region. Moreover, the European market second largest
market for Global Influenza Diagnostics. In Europe, Western Europe accounts the
largest market share. While Asia-Pacific is expected to grow at significant
rate in the Global Influenza Diagnostics market during the forecasted period.
Middle East and Africa is likely to have a limited growth in the market due to
less awareness of these therapies and treatment.
Table of Content
1. Report
Prologue
2. Introduction
3. Research
Methodology
4. Market
Dynamics
5. Market Factor
Analysis
6. Global
Influenza Diagnostics Market By Type Of Flu
7. Global
Influenza Diagnostics Market By Test Type
8. Global
Influenza Diagnostics Market By Region
9
Conclusion
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment